News and Views


Nature Medicine 14, 372 - 373 (2008)
doi:10.1038/nm0408-372

Robo4 counteracts VEGF signaling

Lisette M Acevedo1, Sara M Weis1 & David A Cheresh1

  1. Lisette M. Acevedo, Sara M. Weis and David A. Cheresh are in the Department of Pathology and the Moores University of California–San Diego Cancer Center, University of California, San Diego, La Jolla, California 92093-0803, USA. e-mail: dcheresh@ucsd.edu


Robo4 expression in emerging blood vessels can neutralize signaling through the angiogenic factor vascular endothelial growth factor (VEGF) and maintain vessel integrity. The findings could lead to new therapeutic targets for angiogenesis and vascular leakage (pages 448–453).

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Retinal anti-angiogenesis by a new route

Nature Biotechnology News and Views (01 May 2008)


Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT